These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16192842)

  • 21. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
    Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
    Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C
    Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    Ketter TA; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Paulsson B; Mullen J; Vågerö AM
    J Clin Psychopharmacol; 2004 Dec; 24(6):599-606. PubMed ID: 15538120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series.
    Pajonk FG; Schwertner AK; Seelig MA
    J Psychopharmacol; 2006 Jan; 20(1):119-24. PubMed ID: 16204326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
    Adler CM; Fleck DE; Brecher M; Strakowski SM
    J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study.
    Li H; Ma C; Wang G; Zhu X; Peng M; Gu N
    Curr Med Res Opin; 2008 Jan; 24(1):1-10. PubMed ID: 18028587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
    Brown ES; Davila D; Nakamura A; Carmody TJ; Rush AJ; Lo A; Holmes T; Adinoff B; Caetano R; Swann AC; Sunderajan P; Bret ME
    Alcohol Clin Exp Res; 2014 Jul; 38(7):2113-8. PubMed ID: 24976394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
    Yatham LN; Fallu A; Binder CE
    Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P; Taylor M
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia.
    Ganesan S; Agambaram V; Randeree F; Eggens I; Huizar K; Meulien D;
    Curr Med Res Opin; 2008 Jan; 24(1):21-32. PubMed ID: 18021496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
    Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.
    DelBello MP; Adler CM; Whitsel RM; Stanford KE; Strakowski SM
    J Clin Psychiatry; 2007 May; 68(5):789-95. PubMed ID: 17503991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
    Woo YS; Bahk WM; Jon DI; Chung SK; Lee SY; Ahn YM; Pae CU; Cho HS; Kim JG; Hwang TY; Lee HS; Min KJ; Lee KU; Yoon BH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
    McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
    J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine in bipolar disorder: Increasing evidence of efficacy and tolerability.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2004 Oct; 40(10):837-52. PubMed ID: 15605118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Add-on quetiapine for bipolar depression: a 12-month open-label trial.
    Milev R; Abraham G; Zaheer J
    Can J Psychiatry; 2006 Jul; 51(8):523-30. PubMed ID: 16933589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.